FDA Approves First Monthly Atypical Antipsychotic for Schizophrenia

Patient compliance is one of the biggest obstacles to treating the mental disorder schizophrenia. A 2006 study published in the Journal of Clinical Psychiatry found that schizophrenia patients on atypical antipsychotics don’t take their meds for approximately one-third of the year. Another study found...

Bioheart Gets the Go-Ahead for Clinical Trial of Heart Failure Therapy

Bioheart, a developer of cell-based therapies for cardiovascular diseases, has been granted FDA approval to proceed with a Phase I clinical trial for a potential congestive heart failure treatment. Bioheart’s MyoCell SDF-1 therapy modifies stem cells from the patient’s thigh muscle to create...

DATATRAK Awarded Phase III Trial With Top 20 Pharma Company

DATATRAK International, a producer of technical support systems for clinical studies, has been awarded a Phase III clinical trial by the European division of a global Top 20 pharmaceutical company. DATATRAK’s eClinical Solution product will be used in clinical studies held in almost a dozen European...

MuGard: Potential Blockbuster for Oral Mucositis Prevention Market

Oral mucositis is a nearly inevitable complication for patients undergoing chemotherapy or radiation treatment for head or neck cancer. Roughly 100 percent of these patients develop oral mucositis, which is characterized by painful sores in the mouth, infection, and the inability to chew or swallow. Some...

OneMedPlace Partners With Two Television Programs

The Art of Living with Marilu Henner and Inside Business with Fred Thompson have entered into a strategic partnership with OneMedPlace to provide a multi-platform distribution pipeline for quality, educational television programming featuring the latest developments in the world of health, science and...

GSK and Enigma Pair Up to Develop Influenza Diagnostics

GlaxoSmithKline and Enigma Diagnostics have agreed to develop a rapid influenza diagnostic test based on Enigma’s Polymerase Chain Reaction (PCR) technology platform. The new test would analyze swab samples and return an accurate diagnosis in less than 60 minutes at the point of care. Patients...

Wireless Pacemakers Approved for Patient Use

With the U.S. approval of two new wireless devices from St. Jude Medical, pacemaker users may no longer have to see the doctor for follow-up visits. The Accent RF Pacemaker and Anthem RF CRT-P (Cardiac Resychronization Therapy Pacemaker) have been approved by the U.S. Food and Drug Administration. The two...

Biotech Industry Tops for Venture Capital Investors

Although the tough economy has made it difficult for U.S. start-ups to secure funding, the biotechnology industry appears to be rebounding slightly. A new report published by PricewaterhouseCoopers and the National Venture Capital Association found that life sciences companies garnered the most investment...